Bevacizumab and paclitaxel for breast cancer patients with CNS metastases

被引：1
|
作者：
Labidi, S. [1 ]
Bachelot, T. [1 ]
Coquard, I. L. Ray [1 ]
Favier, B. [1 ]
Galy, G. [1 ]
Guastalla, J. [1 ]
机构：
[1] Ctr Leon Berard, F-69373 Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.12009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12009
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
    Abrey, LE
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (06): : 302 - 303
  • [22] Cerebral metastases from breast cancer: The bevacizumab effect
    Mathews, Marlon S.
    Linskey, Mark E.
    Westhout, Franklin D.
    Hasso, Anton N.
    Fruehauf, John P.
    NEURO-ONCOLOGY, 2006, 8 (04) : 446 - 446
  • [23] Fatal hemoptysis in a patient with breast cancer treated with bevacizumab and paclitaxel
    Philippin-Lauridant, G.
    Thureau, S.
    Ouvrier, M. -J.
    Blot, E.
    ANNALS OF ONCOLOGY, 2008, 19 (11) : 1977 - U10
  • [24] Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab
    Polyzos, Aris
    Kalbakis, Kostas
    Kentepozidis, Nikolaos
    Giassas, Stylianos
    Kalykaki, Antonia
    Vardakis, Nikolaos
    Bozionelou, Vasiliki
    Saloustros, Emmanouel
    Kontopodis, Emmanouel
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 217 - 223
  • [25] Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab
    Aris Polyzos
    Kostas Kalbakis
    Nikolaos Kentepozidis
    Stylianos Giassas
    Antonia Kalykaki
    Nikolaos Vardakis
    Vasiliki Bozionelou
    Emmanouel Saloustros
    Emmanouel Kontopodis
    Vassilis Georgoulias
    Dimitris Mavroudis
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 217 - 223
  • [26] Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer
    Wilson, Thomas J.
    Heth, Jason A.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (03) : 468 - 469
  • [27] Association paclitaxel-bevacizumab as treatment for metastatic breast cancer
    Pioud, Virginie
    Chemelle, Mathilde
    Mantelin, Myriam
    Duban, Martine
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 276 - 276
  • [28] POSSIBILITY OF BEVACIZUMAB/PACLITAXEL THERAPY FOR ADVANCED RECURRENT BREAST CANCER PREVIOUSLY TREATED WITH PACLITAXEL
    Hasegawa, Yoshie
    Miura, Motomi
    Yamanaka, Yuji
    Narita, Junichi
    Shibata, Shigeru
    Sutoh, Takemichi
    Akasaka, Harue
    BREAST, 2013, 22 : S51 - S51
  • [29] Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy
    Cottu, P. H.
    Fourchotte, V.
    Vincent-Salomon, A.
    Kriegel, I.
    Fromantin, I.
    JOURNAL OF WOUND CARE, 2011, 20 (09) : 403 - +
  • [30] Patient reported function and symptom burden in breast cancer patients with CNS metastases.
    Fleege, Nicole Margo Grogan
    Pierce-Gjeldum, Donna
    Swartz, Leigh Klaus
    Verbal, Kait
    Merajver, Sofia
    Friese, Christopher Ryan
    Kiyota, Ayano
    Heth, Jason
    Leung, Denise
    Smith, Sean Robinson
    Gabel, Nicolette
    Kim, Michelle Miran
    Morikawa, Aki
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18635 - E18635
12345